[go: up one dir, main page]

NO922936L - Fremstilling av fettsyremedikamenter - Google Patents

Fremstilling av fettsyremedikamenter

Info

Publication number
NO922936L
NO922936L NO92922936A NO922936A NO922936L NO 922936 L NO922936 L NO 922936L NO 92922936 A NO92922936 A NO 92922936A NO 922936 A NO922936 A NO 922936A NO 922936 L NO922936 L NO 922936L
Authority
NO
Norway
Prior art keywords
preparation
acid medicines
aids
fatic acid
fatic
Prior art date
Application number
NO92922936A
Other languages
English (en)
Other versions
NO922936D0 (no
Inventor
David Frederick Horrobin
Michael David Winther
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10698951&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO922936(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Efamol Holdings filed Critical Efamol Holdings
Publication of NO922936D0 publication Critical patent/NO922936D0/no
Publication of NO922936L publication Critical patent/NO922936L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Amplifiers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Anvendelse av en eller flere EFA'er fra n-6-serien og/- eller n-3-serien ved fremstilling av et medikament for lind- ring av symptomene på AIDS, forebygging av utvikling av AIDS eller utvikling av symptomer på AIDS hos HIV-infiserte perso- ner, og en fremgangsmåte for behandling av slike personer.
NO92922936A 1991-07-24 1992-07-23 Fremstilling av fettsyremedikamenter NO922936L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919116054A GB9116054D0 (en) 1991-07-24 1991-07-24 Preparation of fatty acid medicaments

Publications (2)

Publication Number Publication Date
NO922936D0 NO922936D0 (no) 1992-07-23
NO922936L true NO922936L (no) 1993-01-25

Family

ID=10698951

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922936A NO922936L (no) 1991-07-24 1992-07-23 Fremstilling av fettsyremedikamenter

Country Status (12)

Country Link
EP (1) EP0524796B1 (no)
JP (1) JPH05194244A (no)
KR (1) KR930001902A (no)
AT (1) ATE120954T1 (no)
AU (1) AU1968992A (no)
CA (1) CA2073913A1 (no)
DE (1) DE69202019D1 (no)
FI (1) FI923357L (no)
GB (1) GB9116054D0 (no)
IE (1) IE922250A1 (no)
NO (1) NO922936L (no)
ZA (1) ZA925562B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214062A (en) * 1992-04-08 1993-05-25 Clintec Nutrition Co. Method and composition for treating immune disorders, inflammation and chronic infections
US5674901A (en) * 1995-06-01 1997-10-07 Wisconsin Alumni Research Foundation Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
GB9211229D0 (en) * 1992-05-27 1992-07-08 Efamol Holdings Fatty acid treatment
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
WO1995009622A1 (en) * 1993-10-06 1995-04-13 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
US5856149A (en) * 1995-06-01 1999-01-05 Wisconsin Alumni Research Foundation Method of producing conjugated fatty acids
DE19611953A1 (de) * 1996-03-26 1997-10-02 Beiersdorf Ag Verwendung von ungesättigten Monocarbonsäuren gegen Superinfektionen
US7381413B1 (en) 1998-04-17 2008-06-03 University Of Vermont And State Agricultural College Methods and products related to metabolic interactions in disease
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
ES2209658B1 (es) * 2002-12-05 2005-10-01 Proyecto Empresarial Brudy, S.L. Utilizacion del acido docosahexaenoico como principio activo para el tratamiento de la lipodistrofia.
KR20050118057A (ko) * 2004-04-24 2005-12-15 김상희 아세틸디아실글리세롤류의 화합물을 유효성분으로함유하는 항암제 및 건강식품
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
DK1758469T4 (da) * 2004-06-22 2013-11-04 Nutricia Nv Forbedring af barriereintegriteten hos HIV-patienter ved anvendelse af fedtsyrer
JP2006282644A (ja) * 2005-04-05 2006-10-19 Idemitsu Kosan Co Ltd 疲労回復剤
CN101410115B (zh) 2006-03-15 2012-01-04 三得利控股株式会社 含有核黄素和芝麻素类的组合物
EP2117558A4 (en) 2007-01-26 2013-04-03 Univ Colorado METHOD FOR MODULATING THE IMMUNO FUNCTION
SG179481A1 (en) 2007-03-15 2012-04-27 Suntory Holdings Ltd Anti-fatigue agent
MX2010000424A (es) 2007-07-09 2010-08-10 Easter Virginia Medical School Derivados de nucleosidos sustituidos con propiedades antivirales y antimicrobianas.
JP2009073747A (ja) * 2007-09-19 2009-04-09 Suntory Ltd アラキドン酸を有効成分とする抗疲労剤
KR101528380B1 (ko) 2007-09-19 2015-06-11 산토리 홀딩스 가부시키가이샤 세사민류와 아라키돈산류를 함유하는 조성물
WO2020077420A1 (en) * 2018-10-16 2020-04-23 MOREIRA, Nivaldo José Extract of jatropha curcas seed oil

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4017979A1 (de) * 1990-06-05 1991-12-12 Meyer Lucas Gmbh & Co Lipid- bzw. phospholipid-zusammensetzungen sowie diese enthaltendes mittel zur behandlung von erkrankungen sowie auf die zellmembrane zurueckzufuehrende stoerungen

Also Published As

Publication number Publication date
DE69202019D1 (de) 1995-05-18
ZA925562B (en) 1993-04-28
NO922936D0 (no) 1992-07-23
AU1968992A (en) 1993-01-28
FI923357A7 (fi) 1993-01-25
FI923357A0 (fi) 1992-07-23
GB9116054D0 (en) 1991-09-11
KR930001902A (ko) 1993-02-22
ATE120954T1 (de) 1995-04-15
CA2073913A1 (en) 1993-01-25
FI923357L (fi) 1993-01-25
JPH05194244A (ja) 1993-08-03
EP0524796B1 (en) 1995-04-12
IE922250A1 (en) 1993-01-27
EP0524796A1 (en) 1993-01-27

Similar Documents

Publication Publication Date Title
NO922936L (no) Fremstilling av fettsyremedikamenter
SE9500422D0 (sv) New oral pharmaceutical dosage forms
MX9201621A (es) Aminas heterociclicas utiles en la terapia de asma e inflamacion del tracto respiratorio.
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
HU9603042D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration
NO950784L (no) Fettsyrederivater
NO893240D0 (no) Anvendelse av alfa-aminoborsyrederivater til profylaktisk og behandling av virussykdommer.
ES2054715T3 (es) Nuevos derivados de naftaleno y productos farmaceuticos antialergicos y antiinflamatorios.
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
NO962752D0 (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
DK0476113T3 (da) Lægemiddel til behandling af hyperlipidæmi og/eller atherosklerose
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
NO960347L (no) Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
SE9403861D0 (sv) Novel medicinal use
BG94567A (en) Medicaments for the treatment of aids and method for its application
IT8520736A0 (it) Composizione medicinale e metodo per la cura delle periartriti ed affezioni similari.
IT8646805A0 (it) Sussidio per la prevenzione e la cura delle piaghe da decubito
ITMI911930A1 (it) Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico.
NO167709C (no) Innretning for diagnostisering og behandling av nesesykdommer.
IT8741690A0 (it) Farmaco per la profilassi e per la cura delle disbatteriosi vaginali.
FR2668065B1 (fr) Composition pharmaceutique destinee au traitement et a la prevention des infections retrovirales.
IT8719390A0 (it) Composizione farmaceutica per la prevenzione e il trattamento dell'aterosclerosi.
CA2183764A1 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration